The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Helix BioPharma

  • HBP
  • TSX
  • Consumer Products
  • Latest 1.82
  • Currency C$
  • Change 0.0000
  • Percent Change 0.00 %
  • Volume 0
  • Fri Sep 5, 2014 02:29 PM EDT TSX data delayed 15 minutes.
  • Open 0.0000
  • Previous Close 1.82
  • High 0.0000
  • Low 0.0000
  • Bidx1,000 1.65
  • Askx2,500 1.82
  • 52-week High06/13 2.27
  • 52-week Low10/16 1.01
  • Beta 0.347
  • Market Cap 130.87M
  • EPS -0.13
  • P/E
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $88,000
  • Earnings $-8,791,000
  • Return on Equity n/a

Cash Flow

  • Cash Flow $-8,276,000
  • Cash $2,832,000
  • Current Ratio 4.83

12 months ended Apr 30, 2014.

Trailing 12 month results shown above.
All data is in Canadian dollars.

Balance Sheet

  • Assets $3,663,000
  • Liabilities $650,000
  • Liabilities-to-Equity Ratio 0.22

Price Ratios

  • Price to Sales 1,487.11
  • Price to Book 45.50
  • Price to Cash Flow -15.81

Event Calendar

Event Last   Next  
Earnings Jun 17 n/a Nov 4 n/a
Surprises Oct 29 -14.29% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Sep 17, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

HELIX BIOPHARMA CORP. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing products for the prevention and treatment of cancer. Helix's product development initiatives include Topical Interferon Alpha-2b and its new drug candidate L-DOS47 .

Related Securities
Symbol Type Latest % Chg

Officers

  • Robert Verhagen President & C.E.O.
  • Photios Michalargias C.F.O.
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: 13
  • Incorporation: Canada,
    Nov 29, 1983
  • Top 1000 Ranking: Profit: 0
    Revenue: 0
    Assets: 0

Head Office

3-305 Industrial Parkway South
Aurora, ON
L4G 6X7

Phone: (905)-841-2300
Fax: (905)-8412244

helix@helixbiopharma.com
www.helixbiopharma.com

Ideas & Discussion

Live Discussion of HBP on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.